Study Comparing Weekly Taxol and Carboplatin vs Standard Taxol and Carboplatin Regimen for Stage IIIB or IV Non-Small-Cell Lung Cancer

Inclusion criteria: * Confirmation of non-small cell bronchogenic carcinoma (epidermoid, squamous, adeno, large cell anaplastic carcinoma, but no small cell or carcinoid) must be histologically or cytologically confirmed. * No prior antineoplastic chemotherapy, hormonal therapy or therapy with biological response modifiers * No previous irradiation to the only area of measurable disease. Exclusion Criteria: * Past or current history of neoplasm other than the entry diagnosis. Exceptions are curatively treated basal cell or squamous cell skin cancer, carcinoma in situ of the cervix or other cancers treated by surgery or radiation with a disease free survival longer than 5 years. * Patients who have undergone surgery less than 3 weeks prior to enrollment. * History of serious cardiac disease not adequately controlled. * Patients with serious active infections or other serious underlying medical condition. * Uncontrolled diabetes mellitis.